BRIM Biotechnology, Inc.
- Biotech or pharma, therapeutic R&D
BRIM Biotechnology, Inc. is a clinical-stage biopharmaceutical innovator dedicated to developing groundbreaking therapies for ocular surface diseases, glaucoma, and posterior segment disorders. With a focus on unmet medical needs, we leverage proprietary platforms to deliver transformative treatments that enhance patient quality of life. Our pipeline spans regenerative medicine, targeted kinase inhibition, and non-invasive delivery breakthroughs.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}